PT Sarana Meditama Metropolitan Tbk (SAME.JK)
IDR 290.0
(-1.36%)
IDR 290.0
(-1.36%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 323.18 Billion IDR | 72.03% |
| 2022 | 266.67 Billion IDR | -42.74% |
| 2021 | 346.62 Billion IDR | 304.16% |
| 2020 | 60.42 Billion IDR | 33.44% |
| 2019 | 52.07 Billion IDR | -74.75% |
| 2018 | 257.14 Billion IDR | 7.8% |
| 2017 | 219.79 Billion IDR | 59.49% |
| 2016 | 119.08 Billion IDR | 6.53% |
| 2015 | 105.53 Billion IDR | 4.24% |
| 2014 | 106.86 Billion IDR | 24.77% |
| 2013 | 99.77 Billion IDR | 38.67% |
| 2012 | 62.04 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 77.44 Billion IDR | -11.94% |
| 2024 Q1 | 57.45 Billion IDR | 14.2% |
| 2024 Q3 | 91.26 Billion IDR | 11.47% |
| 2023 Q1 | 45.55 Billion IDR | -12.83% |
| 2023 Q4 | 65.15 Billion IDR | 10.64% |
| 2023 Q3 | 58.89 Billion IDR | 35.58% |
| 2023 Q2 | 43.43 Billion IDR | -4.65% |
| 2023 FY | - IDR | 72.03% |
| 2022 Q3 | 62.89 Billion IDR | 1439.72% |
| 2022 Q4 | 52.26 Billion IDR | -16.91% |
| 2022 FY | - IDR | -42.74% |
| 2022 Q1 | 40.42 Billion IDR | 19.0% |
| 2022 Q2 | 4.08 Billion IDR | -89.89% |
| 2021 Q2 | 80.9 Billion IDR | -1.47% |
| 2021 Q3 | 81.85 Billion IDR | 1.18% |
| 2021 Q4 | 33.96 Billion IDR | -58.5% |
| 2021 FY | - IDR | 304.16% |
| 2021 Q1 | 82.11 Billion IDR | 175.37% |
| 2020 FY | - IDR | 33.44% |
| 2020 Q1 | 26 Billion IDR | 111.78% |
| 2020 Q2 | -936.37 Million IDR | -103.6% |
| 2020 Q3 | 14.1 Billion IDR | 1606.34% |
| 2020 Q4 | 29.81 Billion IDR | 111.4% |
| 2019 Q1 | 57.58 Billion IDR | 37.79% |
| 2019 FY | - IDR | -74.75% |
| 2019 Q4 | 12.28 Billion IDR | 117.5% |
| 2019 Q3 | -70.16 Billion IDR | -229.16% |
| 2019 Q2 | 54.31 Billion IDR | -5.68% |
| 2018 Q3 | 50.5 Billion IDR | -11.65% |
| 2018 FY | - IDR | 7.8% |
| 2018 Q1 | 55.28 Billion IDR | 58.91% |
| 2018 Q2 | 57.16 Billion IDR | 3.4% |
| 2018 Q4 | 41.79 Billion IDR | -17.24% |
| 2017 FY | - IDR | 59.49% |
| 2017 Q1 | 48.45 Billion IDR | 15.44% |
| 2017 Q2 | 37.26 Billion IDR | -23.09% |
| 2017 Q3 | 40.63 Billion IDR | 9.02% |
| 2017 Q4 | 34.79 Billion IDR | -14.38% |
| 2016 Q1 | 49.41 Billion IDR | -12.73% |
| 2016 FY | - IDR | 6.53% |
| 2016 Q4 | 41.97 Billion IDR | 18.45% |
| 2016 Q3 | 35.43 Billion IDR | 557.54% |
| 2016 Q2 | -7.74 Billion IDR | -115.67% |
| 2015 Q2 | 30.13 Billion IDR | 32.93% |
| 2015 Q1 | 22.66 Billion IDR | -26.45% |
| 2015 FY | - IDR | 4.24% |
| 2015 Q4 | 56.62 Billion IDR | 2293.35% |
| 2015 Q3 | 2.36 Billion IDR | -92.15% |
| 2014 Q2 | 26.23 Billion IDR | 15.98% |
| 2014 FY | - IDR | 24.77% |
| 2014 Q4 | 30.81 Billion IDR | 11.38% |
| 2014 Q1 | 22.62 Billion IDR | -4.66% |
| 2014 Q3 | 27.66 Billion IDR | 5.45% |
| 2013 Q1 | 21.37 Billion IDR | 37.11% |
| 2013 Q3 | 26.89 Billion IDR | 4.54% |
| 2013 Q4 | 23.72 Billion IDR | -11.77% |
| 2013 FY | - IDR | 38.67% |
| 2013 Q2 | 25.72 Billion IDR | 20.38% |
| 2012 FY | - IDR | 0.0% |
| 2012 Q4 | 15.58 Billion IDR | -18.03% |
| 2012 Q3 | 19.01 Billion IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Bundamedik Tbk | 223.9 Billion IDR | -44.339% |
| PT Metro Healthcare Indonesia Tbk | -7.68 Billion IDR | 4308.032% |
| PT Medikaloka Hermina Tbk | 1584.42 Billion IDR | 79.602% |
| PT Mitra Keluarga Karyasehat Tbk | 1555.38 Billion IDR | 79.222% |
| PT Murni Sadar Tbk | 155.6 Billion IDR | -107.693% |
| PT Famon Awal Bros Sedaya Tbk | 443.01 Billion IDR | 27.048% |
| PT Royal Prima Tbk | 52.4 Billion IDR | -516.674% |
| PT Kedoya Adyaraya Tbk | 61.12 Billion IDR | -428.756% |
| PT Siloam International Hospitals Tbk | 2692.46 Billion IDR | 87.997% |
| PT Sejahteraraya Anugrahjaya Tbk | 437.22 Billion IDR | 26.083% |